Fibrinogen Reduction and Motor Function Improvement by Hematopoietic Growth Factor Treatment in Chronic Stroke in Aged Mice: A Treatment Frequency Study.

@article{Liu2016FibrinogenRA,
  title={Fibrinogen Reduction and Motor Function Improvement by Hematopoietic Growth Factor Treatment in Chronic Stroke in Aged Mice: A Treatment Frequency Study.},
  author={Yanying Liu and Maria Popescu and Sharon L. Longo and Mei Gao and Dongliang Wang and Sandra McGillis and Li-Ru Zhao},
  journal={Cell transplantation},
  year={2016},
  volume={25 4},
  pages={729-34}
}
Stroke is a serious medical condition that causes long-term neurological disability in mainly elderly adults worldwide. Lack of therapy to improve functional recovery in the chronic phase of stroke is a major challenge for stroke research. Combining two hematopoietic growth factors, stem cell factor (SCF) and granulocyte-colony stimulating factor (G-CSF), our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke… CONTINUE READING

2 Figures & Tables

Connections & Topics

Mentioned Connections BETA
This study provides new insight into understanding the potential contribution of SCF + G - CSF in both reducing the risk of recurrent ischemic stroke and enhancing stroke recovery .
This study provides new insight into understanding the potential contribution of SCF + G - CSF in both reducing the risk of recurrent ischemic stroke and enhancing stroke recovery .
This study provides new insight into understanding the potential contribution of SCF + G - CSF in both reducing the risk of recurrent ischemic stroke and enhancing stroke recovery .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Stroke is a serious medical condition that causes long - term neurological disability in mainly elderly adults worldwide .
Stroke is a serious medical condition that causes long - term neurological disability in mainly elderly adults worldwide .
Stroke is a serious medical condition that causes long - term neurological disability in mainly elderly adults worldwide .
This study provides new insight into understanding the potential contribution of SCF + G - CSF in both reducing the risk of recurrent ischemic stroke and enhancing stroke recovery .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
Combining two hematopoietic growth factors , stem cell factor ( SCF ) and granulocyte - colony stimulating factor ( G - CSF ) , our previous studies have demonstrated the neurovascular restorative efficacy of this treatment in the chronic phase of experimental stroke .
All Topics